Page 155 - 79_01

Sesión
científica
Premios
Nobel
2012

7.
Overington,
J.
P.;

Al-­-Lazikani,

B.
How
many
drug
targets
are
there?.

Nat
Rev
Drug
Discov
5,

993-­-996
(2006).

8.
Tyndall,
J.
D.;
R.
Sandilya.
GPCR
agonists
and
antagonists
in
the
clinic.
Med
Chem

1,
405-­-421

(2005).

9.
Langley,
J.
N.
Observations
on
the
physiological
action
of
extracts
of
the
supra-­-renal
bodies.
J

Physiol
27,

237-­-256
(1901).

10.
Dale,
H.
H.
On
some
physiological
actions
of
ergot.

J
Physiol
34,
163-­-206
(1906).

11.
Ahlquist,
R.
P.

Adrenergic
receptors:
a
personal
and
practical
view.
Perspect
Biol
Med
17,

119-­-122
(1973).

12.
Rall,
T.
W.;

Sutherland,
E.
W.
Formation
of
a
cyclic
adenine
ribonucleotide
by
tissue

particles.

J
Biol
Chem
232,
1065-­-1076.
(1958).

13.
Walsh,
D.
A.:

Perkins,
J.
P.

et
al.
An
adenosine
3',5'-­-monophosphate-­-dependant
protein

kinase
from
rabbit
skeletal
muscle.
J
Biol
Chem

243,

3763-­-3765
(1968).

14.
Rodbell,
M.;
Birnbaumer,

L.

et
al.
The
glucagon-­-sensitive
adenyl
cyclase
system
in
plasma

membranes
of
rat
liver.
V.
An
obligatory
role
of
guanylnucleotides
in
glucagon
action.
J

Biol
Chem

246,
1877-­-1882
(1971).

15.

Ross,
E.
M.;
Gilman
A.
G.
Resolution
of
some
components
of
adenylate
cyclase
necessary
for

catalytic
activity.

J
Biol
Chem
252,

6966-­-6969
(1977).

16.
Lefkowitz,
R.
J.;
Mukherjee,
C.
et
al.
Stereospecific
(3H)(minus)-­-alprenolol
binding
sites,

beta-­-adrenergic
receptors
and
adenylate
cyclase.
Biochem
Biophys
Res
Commun

60,
703-­-
709
(1974).

17.
De
Lean,
A.;
Stadel,
J.
M.

et
al.
A
ternary
complex
model
explains
the
agonist-­-specific

binding
properties
of
the
adenylate
cyclase-­-coupled
beta-­-adrenergic
receptor.
J
Biol
Chem

255,
7108-­-7117
(1980).

18.
Limbird,
L.
E.;
Gill,
D.
M.

et
al.
Agonist-­-promoted
coupling
of
the
beta-­-adrenergic
receptor

with
the
guanine
nucleotide
regulatory
protein
of
the
adenylate
cyclase
system.
Proc
Natl

Acad
Sci
USA
77,

775-­-779
(1980).

19.
Kent,
R.A.;
DeLean,
A;
Lefkowitz,
R.J.
A
quantitative-­-analysis
of
beta-­-adrenergic
receptors

interactions:
resolution
of
high
and
low
affinity
states
of
the
receptor
by
computer

modeling
of
ligand
binding
data.
Mol.
Pharm.
17,
14-­-23.
(1979)

20.
Caron,
M.
G.
;
Lefkowitz,

R.
J.
Solubilization
and
characterization
of
the
beta-­-adrenergic

receptor
binding
sites
of
frog
erythrocytes.
J
Biol
Chem
251,
2374-­-2384

(1976).

21.
Shorr,
R.
G.;
Lefkowitz,
R.
J.
et
al.
Purification
of
the
beta-­-adrenergic
receptor.
Identification

of
the
hormone
binding
subunit.

J
Biol
Chem
256,
5820-­-5826
(1981).

22.
Benovic,
J.
L.;
Shorr,
R.
G.
et
al.
The
mammalian
beta
2-­-adrenergic
receptor:
purification
and

characterization.
Biochemistry
23(20):
4510-­-4518
(1984).

23.
Lefkowitz,
R.
J.
Seven
transmembrane
receptors:
a
brief
personal
retrospective.
Biochim

Biophys
Acta

1768

748-­-755
(2007).

24.
Lefkowitz,
R.
J.

Historical
review:
a
brief
history
and
personal
retrospective
of
seven-­-
transmembrane
receptors."
Trends
Pharmacol
Sci
25(8):
413-­-422
(2004).

25.
Dixon,
R.
A.;

B.
K.
Kobilka,
et
al.
Cloning
of
the
gene
and
cDNA
for
mammalian
beta-­-
adrenergic
receptor
and
homology
with
rhodopsin.
Nature
321,
75-­-79
(1986).

26.
Benovic,
J.
L.;
F.
Mayor,
Jr.,
et
al.

Light-­-dependent
phosphorylation
of
rhodopsin
by
beta-­-
adrenergic
receptor
kinase.
Nature

321,
869-­-872
(1986).

27.
Kubo,
T.;

Fukuda,
K.
et
al.
Cloning,
sequencing
and
expression
of
complementary
DNA

encoding
the
muscarinic
acetylcholine
receptor.
Nature
323,

411-­-416
(1986).

149